Profile data is unavailable for this security.
About the company
Microbot Medical Inc. is a pre-clinical medical device company. The Company is focused on the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms are comprised of ViRob, TipCAT and Liberty, including certain CardioSert assets. Using the ViRob platform, Microbot is developing the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH). Utilizing the Liberty and CardioSert platforms, it is developing disposable robot for various endovascular interventional procedures. ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. TipCAT is a disposable self-propelled locomotive device, designed to advance in tubular anatomies. Liberty is a disposable robotic system, designed to move guidewires and over-the-wire devices, such as microcatheters within the body’s vasculature.
- Revenue in USD (TTM)0.00
- Net income in USD-10.01m
- Incorporated1988
- Employees12.00
- LocationMicrobot Medical Inc25 RECREATION PARK DR SUITE 108HINGHAM 02043United StatesUSA
- Phone+1 (908) 938-5561
- Fax+1 (302) 655-5049
- Websitehttp://www.microbotmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Virios Therapeutics LLC | 0.00 | -16.56m | 46.73m | 3.00 | -- | 2.04 | -- | -- | -1.90 | -1.90 | 0.00 | 2.74 | 0.00 | -- | -- | 0.00 | -132.32 | -- | -148.68 | -- | -- | -- | -- | -- | -- | -89.26 | 0.00 | -- | -- | -- | -318.27 | -- | -- | -- |
| NanoViricides Inc | 0.00 | -8.62m | 46.94m | 17.00 | -- | 1.47 | -- | -- | -0.858 | -0.858 | 0.00 | 2.77 | 0.00 | -- | -- | 0.00 | -34.99 | -39.68 | -37.33 | -45.48 | -- | -- | -- | -- | -- | -70.71 | 0.0052 | -- | -- | -- | -59.61 | -- | -73.62 | -- |
| Navidea Biopharmaceuticals Inc | 872.43k | -11.95m | 47.05m | 13.00 | -- | 8.24 | -- | 53.94 | -0.4377 | -0.4377 | 0.0318 | 0.1892 | 0.0949 | -- | 0.271 | 67,110.00 | -123.60 | -105.66 | -259.57 | -- | 99.99 | 98.21 | -1,302.50 | -618.75 | 2.45 | -3,621.85 | 0.00 | -- | 39.10 | -41.41 | -4.02 | -- | 44.33 | -- |
| Greenlink International Inc | 1.32m | -1.00m | 47.92m | 10.00 | -- | -- | -- | 36.34 | -0.0031 | -0.0031 | 0.0041 | -0.007 | 1.19 | 40.41 | 28.46 | -- | -90.30 | -70.66 | -- | -- | 0.4247 | 19.02 | -76.05 | -26.76 | 0.0653 | -8.92 | -- | -- | -30.19 | -12.02 | 24.15 | -- | -- | -- |
| Forte Biosciences Inc | 0.00 | -20.29m | 48.08m | 10.00 | -- | 0.9634 | -- | -- | -1.61 | -1.61 | 0.00 | 3.54 | 0.00 | -- | -- | 0.00 | -49.98 | -72.22 | -54.27 | -90.79 | -- | -- | -- | -1,273.90 | -- | -- | 0.00 | -- | -100.00 | -- | 26.81 | -- | -- | -- |
| Rapid Therapeutic Science Laborators Inc | 2.05k | -2.56m | 48.39m | -- | -- | 122.02 | -- | 23,602.67 | -0.0143 | -0.0143 | 0.00001 | 0.002 | 0.0027 | 0.0105 | -- | -- | -333.55 | -- | -- | -- | 49.76 | -- | -124,652.70 | -- | 0.1027 | -47.66 | 0.5307 | -- | -- | -- | -- | -- | -- | -- |
| BioCardia Inc | 195.00k | -13.29m | 48.59m | 24.00 | -- | 3.10 | -- | 249.18 | -0.9135 | -0.9135 | 0.0131 | 0.929 | 0.0117 | -- | 0.8804 | 8,125.00 | -79.73 | -97.01 | -109.63 | -118.62 | 82.56 | 8.68 | -6,816.92 | -2,616.10 | -- | -- | 0.00 | -- | -79.58 | -30.65 | -2.01 | -- | -- | -- |
| Windtree Therapeutics Inc | 0.00 | -62.82m | 48.60m | 31.00 | -- | 0.8562 | -- | -- | -2.91 | -2.91 | 0.00 | 2.13 | 0.00 | -- | -- | 0.00 | -57.32 | -41.97 | -62.19 | -51.71 | -- | -- | -- | -2,512.43 | -- | -1,616.85 | 0.2218 | -- | -100.00 | -- | -18.53 | -- | -8.67 | -- |
| Nugenerex Immuno-Oncology Inc | 0.00 | -6.29m | 49.15m | 6.00 | -- | -- | -- | -- | -0.0291 | -0.0291 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -244.01 | -- | -- | -- | -- | -- | -- | -- | -- | -5.43 | -- | -- | -- | -- | -43.39 | -- | -- | -- |
| Microbot Medical Inc | 0.00 | -10.01m | 49.19m | 12.00 | -- | 2.44 | -- | -- | -1.41 | -1.41 | 0.00 | 2.83 | 0.00 | -- | -- | 0.00 | -38.66 | -57.64 | -40.26 | -68.96 | -- | -- | -- | -- | -- | -101.12 | 0.00 | -- | -- | -- | -26.52 | -- | 114.59 | -- |
| Universe Pharmaceuticals Inc | 38.61m | 9.63m | 49.37m | 227.00 | 4.05 | 0.974 | 4.90 | 1.28 | 0.5604 | 0.5604 | 2.08 | 2.33 | 0.821 | 4.25 | 3.48 | 170,079.50 | 20.48 | -- | 28.26 | -- | 45.49 | -- | 24.95 | -- | 3.43 | 174.21 | 0.1037 | -- | -7.60 | -- | 0.0894 | -- | -- | -- |
| Trinity Biotech plc (ADR) | 116.22m | -1.51m | 49.75m | 543.00 | -- | -- | 31.65 | 0.428 | -0.072 | -0.09 | 5.56 | -0.0206 | 0.9171 | 1.87 | 7.17 | 214,025.80 | -1.19 | -13.81 | -2.41 | -15.52 | 46.79 | 43.74 | -1.30 | -27.48 | 0.4427 | 3.73 | 1.01 | -- | 12.77 | 0.3538 | 79.26 | -- | -17.44 | -- |
| Cell Source Inc | 0.00 | -6.32m | 49.97m | -- | -- | -- | -- | -- | -0.2082 | -0.2082 | 0.00 | -0.3011 | 0.00 | -- | -- | -- | -2,773.37 | -1,209.56 | -- | -- | -- | -- | -- | -- | -- | -2.87 | -- | -- | -- | -- | -4.22 | -- | -- | -- |
| Skye Bioscience Inc | 0.00 | -6.98m | 49.99m | 6.00 | -- | 20.89 | -- | -- | -0.0218 | -0.0218 | 0.00 | 0.0057 | 0.00 | -- | -- | 0.00 | -244.37 | -390.82 | -694.15 | -- | -- | -- | -- | -- | -- | -9.51 | 0.4236 | -- | -- | -- | -723.74 | -- | 29.57 | -- |
| Baudax Bio Inc | 543.00k | -37.60m | 51.06m | 57.00 | -- | -- | -- | 94.03 | -0.3967 | -0.3967 | 0.0116 | -0.0543 | 0.0073 | 1.15 | 1.81 | 9,526.32 | -50.37 | -- | -65.21 | -- | -358.38 | -- | -6,924.13 | -- | 2.87 | -27.12 | 2.31 | -- | -- | -- | -133.74 | -- | -- | -- |
| Acorda Therapeutics Inc | 151.90m | -132.02m | 52.17m | 167.00 | -- | 0.2735 | -- | 0.3435 | -15.34 | -15.34 | 10.92 | 17.15 | 0.2491 | 1.59 | 10.55 | 909,562.90 | -21.65 | -10.88 | -26.04 | -12.29 | 69.52 | 78.62 | -86.91 | -31.14 | 1.29 | -1.54 | 0.475 | -- | -20.50 | -20.86 | 63.51 | -- | -9.08 | -- |
Data as of Sep 16 2021. Currency figures normalised to Microbot Medical Inc's reporting currency: US Dollar USD
10.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2021 | 266.45k | 3.75% |
| BlackRock Fund Advisorsas of 30 Jun 2021 | 137.39k | 1.93% |
| Contego Capital Group, Inc.as of 30 Jun 2021 | 100.00k | 1.41% |
| Dimensional Fund Advisors LPas of 30 Jun 2021 | 53.38k | 0.75% |
| Geode Capital Management LLCas of 30 Jun 2021 | 50.50k | 0.71% |
| Renaissance Technologies LLCas of 30 Jun 2021 | 40.11k | 0.56% |
| SSgA Funds Management, Inc.as of 30 Jun 2021 | 34.47k | 0.49% |
| The Bank of New York Mellon Corp. (Investment Management)as of 30 Jun 2021 | 15.60k | 0.22% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2021 | 11.88k | 0.17% |
| Steward Partners Investment Advisory LLCas of 30 Jun 2021 | 11.60k | 0.16% |
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
